Telomir Pharmaceuticals, Inc. (TELO)

Last Closing Price: 1.45 (2026-04-17)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Telomir Pharmaceuticals, Inc. (TELO) Revenue data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
Revenue
--
$-2.06M
--
--
$2.13M
$-2.13M
$0.07M
$-2.06M
$-2.06M
$-2.06M
$-2.06M
$-2.06M
$-2.06M
$-2.13M
$-2.13M
31.65M
31.65M
$-0.06
$-0.06
Balance Sheet Financials
$7.34M
--
--
$7.34M
$1.43M
--
--
$1.43M
$5.91M
$5.91M
$5.91M
34.38M
Cash Flow Statement Financials
$-3.69M
--
$9.71M
$1.27M
$7.29M
$6.02M
$5.29M
--
--
Fundamental Metrics & Ratios
5.14
--
--
--
--
--
--
--
--
--
--
$-3.69M
--
--
--
--
--
--
--
-34.86%
-34.86%
-28.08%
-34.86%
$0.17
$-0.12
$-0.12